Effective March 8th 2018 Permitted indications are now available through eBS for listed medicines.

The TGA has implemented a list of permitted indications for medicines listed under Section 26A of the Therapeutic Goods Act 1989 (the Act).

The list of permitted indications can be accessed via the Therapeutic Goods (Permissible Indications) Determination.

The list of permitted indications implements one of the Government’s reforms to the regulatory framework for complementary medicines arising from the Medicines and Medical Devices Regulation Review (MMDR). The reforms aim to provide better transparency on what indications are suitable for listed medicines to help prevent sponsor non-compliance and also provides greater protection for consumers from misleading and inappropriate claims.

Effective from 6 March